SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence
03. April 2020 10:15 ET
|
SIGA Technologies Inc.
- Contract for up to $14.3 million for 15,325 Courses - NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused...
SIGA Technologies, Inc. Reports Financial Results for Fiscal Year 2019
05. März 2020 16:05 ET
|
SIGA Technologies Inc.
- Announces Expectations for Product Delivery to BARDA -- Announces $50 Million Share Repurchase Program -- Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 05, 2020 (GLOBE...
SIGA Announces Collaboration with Turnstone Biologics
02. März 2020 16:30 ET
|
SIGA Technologies Inc.
SIGA to supply TPOXX® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...
SIGA to Host Business Update Call on March 5, 2020 after Release of Year End Financial Results
20. Februar 2020 16:59 ET
|
SIGA Technologies Inc.
NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX®
05. Dezember 2019 12:10 ET
|
SIGA Technologies Inc.
Contract Would Represent First International Order of TPOXX Canadian Military Intends Firm Delivery of 2,500 Courses, with Additional Option Quantities of 12,825 Courses NEW YORK, Dec. 05, 2019 ...
SIGA Announces Canadian Release of the Advanced Contract Award Notice to Support Regulatory Filing for Oral TPOXX®
18. November 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the...
SIGA Technologies CEO to Speak at NCT Asia Conference on October 23, 2019
21. Oktober 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020
03. Oktober 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019
26. September 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019
25. September 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....